Newsletter - All News

Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research

Category

Continent

From

To

United Laboratories, Novo Nordisk Sign Global Lice...

United Laboratories, Novo Nordisk Sign Global Lice...

Category : Licensing/Collaboration Deal 27 March 2025

The United Laboratories International Holdings Limited (TUL), a firm mainly engaged in the R&D,...

FDA Grants Priority Review to Sanofi's Tolebrutini...

FDA Grants Priority Review to Sanofi's Tolebrutini...

Category : Clinical Trial Update 26 March 2025

The US Food and Drug Administration (FDA) is evaluating under priority review the regulatory submiss...

Clover Biopharma Begins RSV Vaccine Trial After US...

Clover Biopharma Begins RSV Vaccine Trial After US...

Category : Approval/Launch 26 March 2025

Clover Biopharmaceuticals, Ltd.?, a global commercial-stage biotechnology company committed to unlea...

Clearmind’s FDA-Approved CMND-100 Trial Moves Forw...

Clearmind’s FDA-Approved CMND-100 Trial Moves Forw...

Category : Clinical Trial Update 26 March 2025

Clearmind Medicine Inc, a clinical-stage biotech company focused on discovery and development of nov...

United Labs & Novo Nordisk Sign $2B Deal for Obesi...

United Labs & Novo Nordisk Sign $2B Deal for Obesi...

Category : Licensing/Collaboration Deal 25 March 2025

An exclusive license agreement for UBT251, a triple agonist of the receptors for GLP-1, GIP, and glu...

‹
1
2

Subscribe to Our Newsletter!

Subscribe to get latest updates and information.